PuSH - Publikationsserver des Helmholtz Zentrums München

Kreyling, W.G. ; Holzwarth, U.* ; Haberl, N. ; Kozempel, J.* ; Hirn, S. ; Wenk, A. ; Schleh, C. ; Schäffler, M. ; Lipka, J. ; Semmler-Behnke, M. ; Gibson, N.*

Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats (Part 1).

Nanotox. 11, 434-442 (2017)
Postprint Forschungsdaten DOI PMC
Open Access Green
Submicrometer TiO2 particles, including nanoparticulate fractions, are used in an increasing variety of consumer products, as food additives and drug delivery applications are envisaged. Beyond exposure of occupational groups this entails an exposure risk to the public. However, nanoparticle translocation from the organ of intake and potential accumulation in secondary organs is poorly understood and in many investigations excessive doses are applied. The present study investigates the biokinetics and clearance of a low single dose (typically 40-400 µg/kg BW) of (48)V-radiolabeled, pure TiO2 anatase nanoparticles ([(48)V]TiO2NP) with a median aggregate/agglomerate size of 70 nm in aqueous suspension after intravenous injection into female Wistar rats. Biokinetics and clearance were followed from 1-hour to 4-weeks. The use of radiolabeled nanoparticles allowed a quantitative [(48)V]TiO2NP balancing of all organs, tissues, carcass and excretions of each rat without having to account for chemical background levels possibly caused by dietary or environmental titanium exposure. Highest [(48)V]TiO2NP accumulations were found in liver (95.5%ID on day-1), followed by spleen (2.5%), carcass (1%), skeleton (0.7%) and blood (0.4%). Detectable nanoparticle levels were found in all other organs. The [(48)V]TiO2NP content in blood decreased rapidly after 24h while the distribution in other organs and tissues remained rather constant until day-28. The present biokinetics study is part 1 of a series of studies comparing biokinetics after three classical routes of intake (intravenous (IV) injection (part 1), ingestion (part 2), intratracheal instillation (part 3)) under identical laboratory conditions, in order to verify the common hypothesis that IV-injection is a suitable predictor for the biokinetics fate of nanoparticles administered by different routes. This hypothesis is disproved by this series of studies.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
6.428
1.251
41
52
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Hepato Biliary Nanoparticle Clearance ; Size-selected ; Accumulation In Organs And Tissues ; Intravenous Injection ; Radiolabeled Titanium Dioxide Nanoparticles ; Translocation Across Organ Membranes; Insoluble Iridium Particles; Tissue Distribution; Gold Nanoparticles; Translocation; Elimination; Clearance; Lung; Size; Nanomaterials; Epithelium
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 1743-5390
e-ISSN 1743-5404
Zeitschrift Nanotoxicology
Quellenangaben Band: 11, Heft: 4, Seiten: 434-442 Artikelnummer: , Supplement: ,
Verlag Informa Healthcare
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
Institute of Lung Health and Immunity (LHI)
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
Lung Research
PSP-Element(e) G-504000-001
G-505000-001
Scopus ID 85016970654
PubMed ID 28290717
Erfassungsdatum 2017-06-12